Apoptosis plays a striking role in the hormone-dependent
Introduction
The control of physiological functions and the fate of an organ often require the elimination of harmful or unnecessary cells, which is, in most cases, dependent on defined conditions and predictable in its consequences. One mechanism by which this programmed cell death (PCD) (Lockshin and Williams, 1964) occurs is apoptosis (Kerr et al, 1972) , a morphologically and biochemically defined event. Apoptosis in its classical form involves a cell-autonomous suicide program often requiring de novo RNA and protein synthesis leading to the elimination of the affected cells in a non-necrotic process without inflammatory reaction . The mechanisms, by which the onset of apoptosis is triggered are under active investigation. Nevertheless, some mediators of apoptotic processes in mammalian cells can already be defined at various physiological levels. Important regulators of apoptosis include the Fas-mediated signal-transduction by a1992) which may be followed by subsequent apoptosis (Yonish-Rouach et al, 1991; Shaw et al, 1992; Ryan et al, 1993) . Genes which are transcriptionally induced by binding of the p53-protein to a promoter-element include Waf1/Cip1 (El-Deiry et al, 1993; Harper et al, 1993) and GADD45 , both of which participate in the p53-dependent growth arrest, as well as the bcl-2 homolog bax (Miyashita and Reed, 1995) . Furthermore, apoptotic processes are often accompanied or even caused by changes in intracellular physiological conditions, i.e. a sharp increase in Ca 2+ -ion concentration (McConkey et al, 1989) . Importantly, several evolutionarily conserved genes, exemplified by the Cenorhabditis elegans gene ced-3 and members of the mammalian interleukin-1b-converting enzyme family (ICE), have been shown recently to regulate programmed cell death processes (Miura et al, 1993; Yuan et al, 1993; Kumar et al, 1994; Wang et al, 1994) .
Hormone dependent apoptosis of secretory epithelial cells can be observed in the involuting mammary gland after weaning (Walker et al, 1989; Strange et al, 1992) and in the ventral prostate following castration (Kerr and Searle, 1973;  for review see Tenniswood et al, 1992) . The mammary gland is a tubuloalveolar organ undergoing repetitive postembryonic differentiation steps between quiescent-and an active, milk-secreting stage. During pregnancy, the ductal epithelial components of the gland grow out and branch into the surrounding stromal tissue, leading finally to the lactating organ. Throughout involution, a dramatic decrease in number of the secretory epithelial cells occurs by apoptosis within a few days after weaning and is accompanied by dramatic tissue remodelling and the proteolytic resolution of the basal lamina, leading ultimately to the reestablishment of the quiescent, fat and stromal tissue dominated organ (Warburton et al, 1982; Daniel and Silberstein, 1987; Pitelka, 1988; Walker et al, 1989) . The involution process of the mammary gland can be considered as being divided into two parallel occurring events: Firstly, tissue remodelling requiring the coordinated action of various metalloproteases and their inhibitors, as well as the activation of mechanisms leading to the reconstitution of stromal components and secondly, the elimination of the secretory epithelial cells by apoptosis in association with the stimulation of cell-autonomous processes, such as protein kinase A-activity and the transcription of certain genes already recognized as being involved in apoptotic processes in other cell types (Dickson and Warburton, 1992; Strange et al, 1992; Talhouk et al, 1992; Li et al, 1995; Marti et al, 1994; Lund et al, 1996) . Most involution associated genes characterized so far seem to be involved in the tissue remodelling, rather than being functionally related to apoptosis. This is reflected by the relative abundance of transcripts in the involuting mammary gland as coding for remodelling proteins. Therefore, more subtle techniques have been needed to detect those less abundant transcripts which are likely to be involved in the apoptotic process itself.
In the rat ventral prostate, another organ where PCD has been extensively studied, apoptosis of the glandular epithelial cells can be experimentally induced by castration. The regressing ventral prostate shows several morphological and biochemical features of apoptosis analogous to the involuting mammary gland (Kerr and Searle, 1973) . We demonstrate here that several features are apoptosis-associated indistinguishable in prostate and mammary glands, following much the same time-course. On the other hand, tissue remodelling in the regressing prostate was much less evident, as it is shown by strikingly different transcription patterns of major tissue remodelling enzymes. The coincident expression of a gene during both mammary and prostate involution points, therefore, rather to an apoptosis-associated process as distinct from tissue remodelling. To identify such genes, which are more likely to participate directly in apoptosis, we compared RNAs from several involution stages of rat mammary and prostate glands in parallel using the`Differential Display'-Assay . Only fragments showing a comparable regulation were chosen for further analysis. We designate this novel application a`Differential Display Coincidence Analysis' (DDC) and describe the characteristics of the several genes identified, which show coincident regulation during involution of the two hormone-dependent glandular tissues.
Results

Mammary and prostate glands show a similar hormone ablation-induced PCD, but differ in tissue remodelling
No DNA-fragmentation was detected in the normal ventral prostate using an in situ DNA fragmentation assay (Gavrieli et al, 1992) , but by 60 h after castration, stained nuclei in the assay indicate the incorporation of labeled nucleotides to free 3' DNA-ends generated by the endonucleolytic activity typical of apoptosis (data not shown).
Using the regressing prostate as an additional model for apoptosis, we examined the expression of two classes of appropriate marker genes in the involuting rat prostate: genes whose specific expression patterns are closely related with apoptotic events in general ( Figure 1a ) and tissue remodelling markers, i.e. various proteases ( Figure  1b) . Compared with analogous gene expression in the involuting mammary gland (Strange et al, 1992) , a notable lack of tissue remodelling response is evident in the regressing prostate. The 72 kD gelatinase which is sharply upregulated in mammary gland tissue, shows no change above the basal level in the prostate. Contrary to the involuting mammary gland, stromelysin-RNA was undetectable in the regressing prostate, as was tissue plasminogen activator (tPA). Urokinase plasminogen activator (uro.PA) which was not significantly up-regulated in mammary gland involution, was weakly expressed and slightly elevated when compared to the normal prostate. Not surprisingly, levels of the tissue inhibitor of metalloproteinases (TIMP)-message were low until day 6 of prostate involution, when a modest elevation could be detected (data not shown).
Regarding apoptosis markers, expression patterns in the involuting prostate were comparable with the mammary gland (see Strange et al, 1992) . Sulphated glycoprotein-2 (SGP-2)-transcription is dramatically increased at day 2 of involution as it is also in the mammary gland, declining by day 6 post-castration. As in mammary gland involution, elevated expression of tissue transglutaminase (TG) is slow, with a peak at day 6 post castration. p53 gene and transforming growth factor-b1 (TGF-b1) gene expression rise similarly in involuting prostate and mammary gland, showing maxima at 2 days and 4 days post-castration, respectively.
Identification and cloning fragments of regulated genes
Several combinations of the 3'-primers T 12 MC, or T 12 MG and 10 different 5'-primers were used for the Differential Display PCR-reactions. Individual reactions were loaded onto denaturing polyacrylamide-gels ( Figure 2 ). As expected, most PCR-fragments were detectable in all developmental stages of each gland after their separation over polyacrylamide-gels. Many other fragments were present in varying combinations, but failed to reveal a (2, 4, 6) were examined in Northern blots for expression of genes encoding several widely accepted apoptosis markers and for enzymes known to be important for tissue remodelling in rodent mammary glands. L indicates PolyA(+) RNA from lactating rat mammary glands and 3 indicates PolyA(+) RNA from mammary glands, 3 days after weaning. Abbreviations are: SGP-2, sulphated glycoprotein-2; TG, tissue transglutaminase; p53, p53 suppressor gene, TGF-b1, transforming growth factor b1; 72 kD Gel., 72 kD gelatinase, uro. PA, urokinase plasminogen activator, tPA, tissue plasminogen activator; stromelysin; (for regulation of these genes during mammary gland involution, see Strange et al, 1992) .
m. g. prostate Figure 2 Differential Display of RNAs derived from various mammary and ventral prostate gland stages before and after involution. 0.2 mg total RNA from each sample were used for PCR-amplification in a`Differential Display' Assay . Amplified fragments were separated over a 6% denaturing polyacrylamide-gel. Mammary gland samples derived from pregnant (P), Lactating (L) and from 2, 4 and 6 days post-weaning tissues. Prostate samples were Normal (V), 2, 4 and 6 days after castration. The arrow indicates the bands which led to the identification of clone DDC-2.
coincidence pattern. Relatively rare cases manifested a coincident expression pattern elevated in both involuting mammary gland and prostate. These were chosen for excision from the Differential Display gels. We isolated preferentially fragments displaying the strongest signal at approximately day 3 of involution in both glands. An example is indicated in Figure 2 and led to the identification of clone DDC-2. The size of the isolates ranged between 350 and 500 base-pairs. Successfully reamplified PCR-fragments from 12 reactions were used for blunt-end cloning into the Bluescript plasmid (Stratagene) and were used for further analysis. Table 1 indicates the primer combinations, from which the isolates derived.
Expression patterns and sequence analysis of DDC-clones during rat mammary gland and prostate involution
After successful subcloning 12 PCR-fragments, single clones were used as probes for Northern analysis. Five mg poly A(+)-enriched RNA-samples from various developmental stages of the mammary gland and the ventral prostate were used as shown in Figure 3 . Of the 12 PCR-fragments initially used for cloning, five presented a coincident regulation during mammary gland and ventral prostate involution as expected and were named DDC-1 to DDC-5 ( Figure 3 ). Two further fragments showed a wide range of hybridization signals on Northern blots, typical for sequences containing repetitive elements. The remaining probes either failed to reveal any detectable signal on Northern blots or were false positives. Expression of DDC-homologous transcripts was in general low during all stages other than involution, with the exception of clone DDC-2 (Figure 3 ), which is relatively strongly expressed in the mammary gland of pregnant animals. Signals were markedly increased with a peak around day three of involution. The two day involution point immediately preceeds the onset of cell death, while day three corresponds to the stage where most of the epithelial cells show DNA fragmentation in both glands. In the prostate and partly in the mammary gland, the signals either decrease in their intensity with time (eg. clones DDC-1 and DDC-5) or show a second peak at a later time point (e.g. clone DDC-3). Notably, with DDC-4, no expression was detected at any pre-involution stage in the mammary gland. In the case of DDC-2 and DDC-4, probes reproducibly detected multiple transcripts.
Sequence analysis of the DDC clones
Sequence analysis revealed in four DDC fragments homologies of various degrees with sequences previously described in other species and in different contexts. DDC-1 revealed ca. 86% homology at the nucleic acid level within the coding region of the murine Integrin Associated Protein (IAP) gene (Lindberg et al, 1993) . DDC-2 represents a region from the transcript encoding the Allograft Inflammatory Factor (AIF-1) (Autieri et al, 1995; Utans et al, 1995) , whereas DDC-3 displays a ca. 90% homology with sequences near the 3'-end of the mouse gas-1 gene (Del Sal et al, 1992) . DDC-5 displays ca. 80% homology with a human expressed sequence tag (Genebank-database No. humgs 01767), and DDC-4 did not reveal significant homologies with any sequences in the EMBL or Genebank-databases.
Expression of DDC clones in different tissues
The relative expression of the different DDCs in various organs and tissues is indicated in Figure 4a . Unsurprisingly, the various DDC genes are expressed in other organs than mammary gland or prostate. Closer analysis shows, however, that for DDC 1,2,3 and 4, expression is highest in organs likely to be participating in programmed cell death. DDC 4 expression is limited to potentially involuting organs such as mammary gland, prostate, uterus and ovary. Since the tissue RNA samples were prepared from pools of 2 ± 4 animals each it was likely, for example, that different oestrus stages were represented. Hence, an experiment was performed ( Figure  4b ) in which ovarian, uterine and mammary gland mRNA was prepared at defined oestrus stages. These data show a strong correlation with oestrus for DDC-4 expression suggesting a role restricted to programmed cell death. The exposure in Figure 4b was performed to allow reasonable quantitation for ovarian RNA samples and allows only a faint recognition of a positive signal in uterus under these conditions and none at all in mammary gland, even after longer exposure times.
Expression of DDC-1 (IAP) and DDC-3 (gas-1) occurs in the mammary secretory epithelial cells which undergo programmed cell death
In situ hybridization was employed to visualize the cells showing increased DDC-1 and DDC-3 expression during the course of mammary involution. The alkaline phosphatase detection method allows the unambiguous recognition of the expressing cell. It is abundantly clear, that for DDC-1, the mammary secretory layer exposed to the alveolar lumen shows a widespread positive reaction with the antisense probe by 2 days (Figure 5d ) which is increased by 4 days (Figure 5f ) postlactation. This reaction is absent either with the sense probe tested on parallel sections, or very low with antisense probe-treated sections of pregnant mammary gland (Figure 5b ). When compared with the Northern blot in Figure  3 , it is notable that the apparently stronger signals at day 4 are detected in relative small clusters after the breakdown of the tissue structure and that this result does not reflect the overall transcript content of the organ. Stromal tissue regions are uniformly negative. Myoepithelial cells seem to be negative, but the morphology does not allow them to be conclusively identified. Sections of rat ventral prostate were analyzed, showing a negative reaction on normal tissue, and a clear reaction product by 3 days after castration (Figure 5h) .
For the DDC-3 antisense probe, a similar reactivity could be demonstrated (Figure 6) visible only after the full collapse of the alveolar structures, obviously consisting of mainly apoptotic cells.
Gas-1 fails to block immediately in the G 1 stage of cell cycle
In considering the possible role of gas-1 in apoptosis, the anology to p53 comes to mind. We performed an experiment, therefore, to examine the possibility that gas-1 imposes a block in transition out of G 1 into the S-phase of the cell cycle. Figure 7a shows that in Balb/c 3T3 cells, the expression of gas-1 is serum dependent, declining sharply within 2 h after serum is added to quiescent, serum-starved cells grown to confluency. Furthermore, in a different experiment, where serum is removed from confluent cultures, the gas-1 induction is sensitive to a cycloheximide or emetine block in protein synthesis imposed at the same time as serum removal ( Figure  7b ). An experiment in which hydroxy urea (HU) blocked entry of freshly trypsinized cells into the S-phase of the cell cycle was employed to show that even cells which have already induced a relatively high gas-1 expression (Figure 7c ) under HU inhibition, nonetheless enter the cell cycle promptly after the inhibitor is washed out (Figure 7d ). Figure 7d shows the plotted results of counts of per cent individual cells incorporating [ 3 H]thymidine in a 1 h label as demonstrated using autoradiography and employing parallel cell cultures to those in Figure 7c . These data indicate that the presence of even relatively high levels of gas-1 expression does not prevent transition from pre-existing late G 1 phase into the S phase of cell cycle.
Discussion Differential Display Coincidence Analysis (DDC) facilitates the detection of genes involved in related physiological processes
Apoptosis is a multistep process and requires the concerted action of different proteins. Previous studies have revealed numerous genes which are differentially expressed during involution of the mammary gland (Strange et al, 1992; Talhouk et al, 1992) , several of them being associated with apoptosis in other tissues. Differential screening protocols led to the identification of further genes regulated during mammary gland involution Li et al, 1995) , some of them represented previously unknown sequences. Since transcripts encoding tissue remodelling proteins are relatively abundant during involution of the mammary gland, they may mask important RNAs from`cell death genes', present at lower levels. To overcome this limitation and to identify genes which are more likely to be important for apoptosis, we used the regressing prostate as a second model in comparison to study apoptosis-associated gene-regulation. To gain evidence for our hypothesis that tissue remodelling during prostate regression is only involved at a minor level, but that apoptosis is as significant as in the mammary gland, we have chosen two classes of probes for Northern blot analysis. The first class consisted of cDNAs from several tissue-remodelling genes, important during mammary gland involution; the second class included fragments ubiquitously associated with apoptosis. The detection of identical expression patterns of individual genes during the regression of both glands should argue therefore rather for a role in apoptosis, but not in the tissue remodelling process. We describe remarkable differences found between prostate and mammary gland regression when using the markers for tissue-remodelling (compare Figure 1b and Strange et al, 1992) . On the other hand, several events known to be associated with programmed cell death in various other tissues, such as the endonucleolytic DNA-fragmentation (Wyllie, 1980) , the rapid increase of SGP-2 transcription (Buttyan et al, 1989; Jenne and Tschopp, 1992) and the regulation patterns of transglutaminase (Fesus et al, 1987) and TGF-b1 (Martikianen et al, 1990; Rotello et al, 1991) were comparable during involution in both glands (Figure 2a ; for comparison see Strange et al, 1992; Li et al, 1995) . Morphological differences between apoptosis in the mammary gland and the ventral prostate have been discussed earlier (Tenniswood et al, 1992) . Our results support the idea that tissue remodelling in the prostate is less evident than in the regressing mammary gland and that similar expression patterns of genes should argue for an analogy to apoptosis. Several strategies exist for identifying differentially expressed genes either in different cell types or in different developmental-or differentiation-stages (Schwartz et al, 1995) . Commonly used protocols include differential screening (St John and Davis, 1979; Williams and Lloyd, 1979) and subtraction strategies (Zimmermann et al, 1980; Hedrick et al, 1984) . Whereas differential screening is the choice when looking for abundantly expressed genes, the sensitivity for the detection of rare transcripts is very limited. This limit can be overcome, when subtractive hybridization or subtractive cloning is used for cell-culture experiments, but the complexity of tissues consisting of multiple cell-types restricts the detection of cell-type specific fragments. Furthermore, genes of interest may be expressed at low, but changing levels throughout all differentiation stages, making the choice of an appropriate subtraction-ratio extremely difficult. For example, apoptosis of cells may occur at a lower level even in non-involuting stages of the mammary gland (Ferguson and Anderson, 1981) and would lead to the subtraction of desired fragments from involuting stages. The Differential Display Assay ) offers a further commonly used strategy for the identification of differentially expressed genes and led to the characterization of many clones (Bauer et al, 1993; Sager et al, 1993) . Using a modification of the original Differential Display protocol, an assay we call the`Differential Display Coincidence Analysis' (DDC), we were able to compare directly the expression patterns of genes expressed in different tissues, but being involved in related processes, by displaying them in parallel on a gel. This led, in our study, to the identification of a variety of genes, potentially involved in apoptosis of both the mammary gland and the rat ventral prostate. Since cell death is hormone dependent in both the mammary gland and the prostate, studies involving DDC-analysis will also reveal apoptosis associated genes for which expression patterns are strictly hormone regulated in both tissues.
The DDC genes and apoptosis
The fact that clone DDC-3 shares greater than 90% homology with a segment located in the 3' untranslated region of the mouse gas-1 RNA argues for its derivation from the rat gas-1 gene. Furthermore, using DDC-3 as a probe, we were not only able to detect a single transcript in mouse mammary gland RNAs corresponding with the published size of gas-1 (Schneider et al, 1988; Del Sal et al, 1992) , but also were able to isolate exclusively mouse gas-1 clones from a mouse mammary gland day 6 involution library (data not shown).
Gas-1, a putative transmembrane protein bearing the RGDmotif of a potential integrin binding protein, has been shown to be transcriptionally strongly induced in NIH 3T3 cells under growth arrest caused either by serum starvation or contact inhibition. NIH 3T3 cells transfected with various viral oncogenes did not express gas-1 even after serum depletion and did not stop growing. Ectopic gas-1 expression in proliferating normal and the oncogene-transfected NIH 3T3 cells was able to induce growth inhibition. Since SV40 Large T antigen transfected cells failed to respond to gas-1 overexpression, it has been speculated, that gas-1 is regulated by proteins like p53 or the retinoblastoma susceptibility protein (Del Sal et al, 1992; . Recently, the chromosomal locus of human gas-1 has been linked to a region, which is frequently deleted in myeloid malignancies (Evdokiou et al, 1993) . The signal is biphasic in the mammary gland, reproducibly declining at day 4 and returning strongly at day 6 in involution. This may hint at the loss of gas-1 expressing epithelial cells by apoptosis and their replacement by a different gas-1 expressing population in late involution. gas-1 is clearly regulated by additional gene products as shown in the cycloheximide sensitivity experiment (Figure 7b ). Furthermore, gas-1 does not induce any cell cycle block in G 1 (Figure  7c ), but seems to exert its function over several rounds of the cell cycle. An increase of intracellular calcium concentrations has been linked to the activation of a specific DNA endonuclease-activity in nuclei of apoptotic cells (Wyllie, 1980; Cohen and Duke, 1984; Arends et al, 1990; Peitsch et al, 1993) , which has been also detected in the involuting mammary gland as well as during ventral prostate regression. (Strange et al, 1992; Colombel et al, 1992) . Furthermore, it has been shown that the application of calcium channel antagonists could markedly delay apoptosis in the ventral prostate after castration (Connor et al, 1988; Kyprianou et al, 1988) . Thus, the high degree of homology between clone DDC-1 and the integrin-associated protein, a regulator of calcium influx (Brown et al, 1990; Lindberg et al, 1993; Schwartz et al, 1993) , reflects a possible role for this molecule during PCD. More recent investigations of IAP point to a specific participation in collaboration with b 3 -integrins, both in transendothelial migration of neutrophils (Cooper et al, 1995) and via an effect on b 1 integrins, on phagocytic activity by K562 cells (Blystone et al, 1995) . The potential for IAP intervention in the apoptotic process is presently being investigated.
The similarity of clone DDC-2 with the sequence of AIF-1, a macrophage factor specifically regulated during rejection of cardiac allografts (Utans et al, 1995) and after carotid artery balloon angioplasty of rats (Autieri et al, 1995) , points to its likely participation in cell death during the involution of the mammary gland and the ventral prostate. Interestingly, the cDNA encoding for AIF-1 was identified in both models by Differential Display (Autieri et al, 1995; Utans et al, 1994) . Since the expression of AIF-1 has been studied by now solely under circumstances, which involve external damage to tissues, it will remain to be interesting learning about its role during non-necrotic, endogenously occurring cell death processes, i.e. during the removal of apoptotic cells.
Whereas DDC-5 displays an 80% homology with an expressed human sequence tag, sequence analysis of clone DDC-4 did not show homology with any known genes and its function has yet to be determined. Nevertheless, the fact that DDC-4 expression is not detectable in pre-involuting stages of the mammary gland and very weak in the normal prostate, is very interesting. Also the very rapid and transient increase of the DDC-4 signal at the time of onset of apoptosis in both tissues points to a very interesting role in involution, as does its dramatic oestrus-dependent expression, mainly detectable in the uterus.
We have presented a modified application for the Differential Display Assay which we call`Differential Display Coincidence Analysis', allowing the detection of genes, regulated during related physiological processes in different tissues. The coincidence suggests that such genes are relevant for this process in general. Furthermore, we have presented evidence that genes regulated in coincidence during involution of the mammary gland and the prostate, are more likely to be linked with apoptosis than with tissue remodelling. With this protocol, we have been able to isolate several examples of coincidence. Precisely which cells are responsible for the expression of the genes described during mammary gland and prostate involution has still to be determined. Nevertheless, their strong regulation in both regressing tissues and the putative functions of the previously characterized homologues speaks for a probable apoptosis-associated function.
Materials and Methods
Induction of involution in mammary and prostate glands
Ventral prostate glands of mature male Sprague Dawley rats were removed from normal-and from 2, 4 and 6 day post-castration animals. Inguinal mammary glands derived from female rats of the same line representing virgin-, pregnant-, lactating-and different involutingstages after forced weaning were isolated.
RNA extraction, Northern blot analysis and differential display
The guanidinium thiocyanate extraction protocol described by Chomczynski and Sacchi (1987) was used for total-RNA isolation from rat mammary and ventral prostate glands. PolyA(+)-enriched RNAs were prepared using oligo dT-cellulose (Boehringer Mannheim). Either 10 mg of total RNA or 5 mg poly(A)-enriched RNA/sample were loaded with glyoxal on a vertical 1% agarose gel in phosphate buffer, electrophoresed and blotted on nitrocellulose filters. Crosslinking was performed with UV-light using the Stratalinker 1800-device (Stratagene, La Jolla CA, USA). Filters were hybridized with random primed and [ 32 P]dCTP labeled fragments in 50% formamide, 46 SSC, 56 Denhardt's solution, 0.2% SDS, 0.1% sodium pyrophosphate and 30 mg/ml salmon sperm DNA at 428C for 16 h. Filters were washed twice at 428C for 30 min in 26 SSC/0.2% SDS, followed by 0.16 SSC/0.2% SDS at 608C. Filters were autoradiographed at 7708C for appropriate times, using intensifier screens.
Hybridization-probes were: stromelysin (Matrisian et al, 1985) ; TIMP (Gewert et al, 1987) ; SGP-2 (Bandyk et al, 1990) ; tTG (Chiocca et al, 1988) ; TGF-b 1 (Derynck et al, 1985) . The tPA-probe was the kind gift of Dr M. O'Connell and Dr N. Waller and a probe for the 72 kD gelatinase was generously provided by Dr L Matrisian.
The`RNAmap' ± Kits A and B (GenHunter Corp., Brookline MA, USA) were used to amplify 0.2 mg DNase I-treated total RNA from each sample as described in the manufacturers description. PCR reactions were run on 6% denaturing polyacrylamide/urea sequencing-gels, and exposed for 24 to 48 h on Kodak X-omat AR films. Bands of interest were excised from the gel and reamplified using the same primers (Table 1) .
Subcloning of PCR-fragments and DNA sequence analysis
After reamplification, AmpliTaq-molecules bound to the PCRfragments were digested with proteinase K (Boehringer Mannheim) directly in the PCR-mixture. Remaining primers were eliminated over a Centricon-100 spin column (Amicon, Beverly MA, USA), the retentate phenolized and chloroform extracted. Precipitated and resolved PCRfragments were blunt-ended using Klenow-fragment (Boehringer) and kinased with T4 polynucleotide kinase (Boehringer) followed by the purification-step over 1% low-melting-point agarose gels (Gibco BRL, Gaithersburg MD, USA). Blunt-end ligation was performed using T4 DNA-ligase (Boehringer) into the dephosphorylated Sma-1 sites of Bluescript plasmids (Stragagene). Ligated constructs were electroporated with the GenePulser (Bio-Rad, Hercules CA, USA) into XL-1 blue bacteria (Stratagene) and plated on LB/ampicilin plates containing X-gal/IPTG (Boehringer) to perform blue-white selection.
Cloned fragments were sequenced on both strands using the dideoxynucleotide chain termination method performed with the Sequenase 2.0 kit (USB, Cleveland OH, USA). Sequence analysis was performed by comparing with the EMBL-Databank or GenebankDatabase.
In situ Hybridization
Bluescript (Stratagene) constructs were used to prepare riboprobes in sense and anti-sense directions for DDC-1 (IAP) and DDC-3 (gas-1). For DDC-1, a full-length clone was employed for in vitro transcription, after which transcripts were fragmented by alkaline hydrolysis to a length of approximately 200 bases. For DDC-3, a subclone extending from base 1261 until the 3' end was isolated and employed to prepare sense and antisense riboprobes similarly hydrolyzed. The transcription reactions were performed with fluorescein-11-dUTP (Amersham International, Little Chalfont, England). Tissue samples were fixed for 16 h in freshly prepared 4% formaldehyde (paraformaldehyde) in phosphate buffered saline at 08C. Embedding was in paraffin at 568C. After sectioning, pre-treatments included proteinase K as above, followed by 5 min postfixation with 4% formaldehyde at 08C, 0.02 M HCl (5 min in water at 228C) and acetylation using conventional protocols. Prehybridization and hybridization were performed in the presence of 50% formamide in 26SSC at 508C. Hybridization was carried out for 16 h, followed by washing in 50% formamide in 26SSC at 508C and washes up to 608C with 0.16SSC. Alkaline phosphataseconjugated anti-FITC Fab fragments (Amersham) were finally used for detection.
